Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;30(1):2219427.
doi: 10.1080/10717544.2023.2219427.

Responsive nanosystems for targeted therapy of ulcerative colitis: Current practices and future perspectives

Min Chen  1 , Huanrong Lan  2 , Ketao Jin  3 , Yun Chen  4
Affiliations

Responsive nanosystems for targeted therapy of ulcerative colitis: Current practices and future perspectives

Min Chen et al. Drug Deliv. 2023 Dec.

Abstract

The pharmacological approach to treating gastrointestinal diseases is suffering from various challenges. Among such gastrointestinal diseases, ulcerative colitis manifests inflammation at the colon site specifically. Patients suffering from ulcerative colitis notably exhibit thin mucus layers that offer increased permeability for the attacking pathogens. In the majority of ulcerative colitis patients, the conventional treatment options fail in controlling the symptoms of the disease leading to distressing effects on the quality of life. Such a scenario is due to the failure of conventional therapies to target the loaded moiety into specific diseased sites in the colon. Targeted carriers are needed to address this issue and enhance the drug effects. Conventional nanocarriers are mostly readily cleared and have nonspecific targeting. To accumulate the desired concentration of the therapeutic candidates at the inflamed area of the colon, smart nanomaterials with responsive nature have been explored recently that include pH responsive, reactive oxygen species responsive (ROS), enzyme responsive and thermo - responsive smart nanocarrier systems. The formulation of such responsive smart nanocarriers from nanotechnology scaffolds has resulted in the selective release of therapeutic drugs, avoiding systemic absorption and limiting the undesired delivery of targeting drugs into healthy tissues. Recent advancements in the field of responsive nanocarrier systems have resulted in the fabrication of multi-responsive systems i.e. dual responsive nanocarriers and derivitization that has increased the biological tissues and smart nanocarrier's interaction. In addition, it has also led to efficient targeting and significant cellular uptake of the therapeutic moieties. Herein, we have highlighted the latest status of the responsive nanocarrier drug delivery system, its applications for on-demand delivery of drug candidates for ulcerative colitis, and the prospects are underpinned.

Keywords: Ulcerative colitis; non – targeted therapy; responsive system; smart nanocarriers.

PubMed Disclaimer

Conflict of interest statement

The authors report there are no competing interests to declare.

Figures

Figure 1.
Figure 1.
Pathophysiology of Ulcerative colitis.
Figure 2.
Figure 2.
Schematic diagram for the commonly used classes of drugs based on severity of the UC.
Figure 3.
Figure 3.
Illustration of smart nanosystems and their potential benefits for colon specific drug delivery.
Figure 4.
Figure 4.
Ulcerative colitis targeted by thermo responsive nanocarrier system via rectal route.
See this image and copyright information in PMC

References

    1. Abbasi M, Sohail M, Minhas MU, et al. ( 2019). Novel biodegradable pH-sensitive hydrogels: An efficient controlled release system to manage ulcerative colitis. Int J Biol Macromol 136: 1–14. - PubMed
    1. Abuchowski A, McCoy JR, Palczuk NC, et al. ( 1977). Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J Biol Chem 252: 3582–6. - PubMed
    1. Aib S, Iqbal K, Khan N, et al. ( 2022). pH-sensitive liposomes for colonic co-delivery of mesalazine and curcumin for the treatment of ulcerative colitis. J Drug Delivery Sci Technol 72: 103335.
    1. Akbarzadeh A, Samiei M, Joo SW, et al. ( 2019). Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line (Retraction of Vol 10, art no 46. BMC CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND. - PMC - PubMed
    1. Alsaad A, Hussien AA, Gareeb MM. ( 2020). Solid lipid nanoparticles (SLN) as a novel drug delivery system: A theoretical review. Syst Rev Pharm 11: 259–73.